Skip to main content
Download PDF

Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells

Stem Cell Research & Therapy volume 12, Article number: 493 (2021) Cite this article

The Original Article was published on 13 July 2021

Correction to: Stem Cell Research & Therapy (2021) 12:394 https://doi.org/10.1186/s13287-021-02458-8

The original article [1] contained an error in Fig. 3B which was given wrong marking figures of NC.U87(0h) and KD.U87(0h).

Fig. 3
figure 3

FOXS1 overexpression induces TMZ resistance in glioma cells. The proliferation (A), wound-healing (B) and apoptosis assay (C) of glioma cells with different FOXS1 expression under 200 μM TMZ treatment. control, normal control; NC, negative control; KD, knockdown; OE, overexpression (n ≥ 3, *P < 0.05, ***P < 0.001)

Full size image

The original figures and data of Fig. 3 were checked by the authors and the editors of this article, no more figure or data was changed.

The corrected Fig. 3 is presented ahead.

Reference

  1. Bing-zhou X, et al. CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Stem Cell Res Ther. 2021;12:394. https://doi.org/10.1186/s13287-021-02458-8.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Bing-zhou Xue and Wei Xiang contributed equally to this work

Authors and Affiliations

  1. Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Bing-zhou Xue, Wei Xiang, Qing Zhang, Hao-fei Wang, Yu-jie Zhou, Han Tian, Ahmed Abdelmaksou, Dong-ye Yi, Nan-xiang Xiong, Xiao-bing Jiang, Hong-yang Zhao & Peng Fu

  2. Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100050, China

    Qing Zhang

  3. Department of Neurosurgery, Faculty of Medicine, Helwan University, Cairo, 11435, Egypt

    Ahmed Abdelmaksou

  4. Henan Vocational University of Science and Technology, Zhoukou, 466000, China

    Jian Xue

  5. Jiangsu Key Lab of Medical Optics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China

    Min-xuan Sun

Authors
  1. Bing-zhou Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Xiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hao-fei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-jie Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Han Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ahmed Abdelmaksou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jian Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Min-xuan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dong-ye Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nan-xiang Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiao-bing Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Hong-yang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Peng Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peng Fu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xue, Bz., Xiang, W., Zhang, Q. et al. Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Stem Cell Res Ther 12, 493 (2021). https://doi.org/10.1186/s13287-021-02566-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-021-02566-5

Stem Cell Research & Therapy

ISSN: 1757-6512